Search Results - "Escriou, G."

P1.44 Neural Baroreceptor Sensitivity in Subjects with Metabolic Syndrome by Zanoli, L., Empana, J. P., Estrugo, N., Escriou, G., Ketthab, H., Pruny, J. F., Laude, D., Thomas, F., Pannier, B., Castellino, P., Jouven, X., Laurent, S., Boutouyrie, P.

“…One of the most common non-invasive techniques to study the baroreflex is the spectral analysis of blood pressure (BP) and heart rate variability. The recent…”
Get full text

1.2 Normal and Reference Values of Baroreceptor Sensitivity: The PPS3 Study by Zanoli, L., Boutouyrie, P., Empana, J. P., Estrugo, N., Escriou, G., Ketthab, H., Pruny, J. F., Laude, D., Thomas, F., Pannier, B., Castellino, P., Jouven, X., Laurent, S.

“…Aims Dysfunction of autonomic control of heart rate is associated with increased mortality. Routine measurement of baroreceptor sensitivity (BRS) for clinical…”
Get full text

Normal and reference values of baroreceptor sensitivity: The PPS3 study by Zanoli, L, Boutouyrie, P, Empana, J.P, Estrugo, N, Escriou, G, Ketthab, H, Pruny, J.F, Laude, D, Thomas, F, Pannier, B, Castellino, P, Jouven, X, Laurent, S

Get full text

Neural baroreceptor sensitivity in subjects with metabolic syndrome by Zanoli, L, Empana, J.P, Estrugo, N, Escriou, G, Ketthab, H, Pruny, J.F, Laude, D, Thomas, F, Pannier, B, Castellino, P, Jouven, X, Laurent, S, Boutouyrie, P

Get full text

984P Phase I dose escalation trial of nintedanib in combination with pembrolizumab in patients with advanced solid tumors (PEMBIB trial) by Baldini, C., Danlos, F-X., Varga, A., Halse, H., Mouraud, S., Cassard, L., Bredel, D., Escriou, G., Parpaleix, A., Rafie, S., Abbassi, A.E., Laghouati, S., Farhane, S., Tselikas, L., Texier, M., Adam, J., Chaput, N., Soria, J-C., Massard, C., Marabelle, A.

Get full text